Find clinical trials for Multiple Myeloma in Madrid, MD
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Myeloma trials near Madrid, MD, ESP:
(DRd) to that of lenalidomide and dexamethasone (Rd), in terms of progression-free survival in participants with relapsed or refractory multiple...
Phase 3
Madrid, Spain and 145 other locations
This study is researching an investigational drug called linvoseltamab ("study drug") in participants at high risk of developing multiple my ...
Phase 2
Madrid, Spain and 14 other locations
The purpose of this study is to evaluate the safety and preliminary efficacy of CC-92480 in combination with standard treatments.
Phase 1, Phase 2
Madrid, Spain and 48 other locations
Patients included in the study will receive induction treatment during 6 months, followed by receive high-dose therapy followed by peripheral blood s...
Phase 2
Madrid, Spain and 15 other locations
A Phase 2, open-label, dose escalation study to evaluate the safety and efficacy of venetoclax in combination with carfilzomib-dexamethasone (Kd) in...
Phase 2
Madrid, Spain and 31 other locations
after Intensification therapy) and safety of Tec-Dara (Teclistamab+Daratumumab) and Tal-Dara (Talquetamab+Daratumumab) in de novo high-risk multiple...
Phase 2
Madrid, Spain and 9 other locations
versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Autologous Stem Cell Transplant (ASCT) in newly diagnosed multiple...
Phase 3
Madrid, Spain and 126 other locations
Multiple Myeloma (MM) is a cancer of the blood's plasma cells ( blood cell). The cancer is typically found in the bones and bone ma...
Phase 1
Majadahonda, Madrid, Spain and 29 other locations
provide clinical benefit in participants with relapsed/refractory multiple myeloma. Elranatamab is a bispecific antibody: binding o ...
Phase 2
Madrid, Spain and 77 other locations
monotherapy (control) in participants with newly diagnosed multiple myeloma after undergoing autologous stem cell transplant. In Pa...
Phase 3
Madrid, Spain and 218 other locations
Clinical trials
Research sites
Resources
Legal